Jiangsu Nanfang Medical Co (SHSE:603880) Accounts Payable: ¥245.8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603880 Jiangsu Nanfang Medical Co Ltd SHSE:603880
51 GF Score
Price ¥7.48
GF Value ¥4.71
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Jiangsu Nanfang Medical Co Accounts Payable?

Jiangsu Nanfang Medical Co SHSE:603880 +3.31% 51 Accounts Payable is ¥245.8 Mil as of Mar. 2026. GuruFocus rates SHSE:603880 with a GF Score™ of 51/100 and a GF Value™ of ¥4.71 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Jiangsu Nanfang Medical Co's Accounts Payable for the quarter that ended in Mar. 2026 was ¥245.8 Mil.

Jiangsu Nanfang Medical Co's quarterly Accounts Payable increased from Sep. 2025 (¥225.1 Mil) to Dec. 2025 (¥245.8 Mil) but then declined from Dec. 2025 (¥245.8 Mil) to Mar. 2026 (¥245.8 Mil).

Jiangsu Nanfang Medical Co's annual Accounts Payable increased from Dec. 2023 (¥215.4 Mil) to Dec. 2024 (¥223.1 Mil) and increased from Dec. 2024 (¥223.1 Mil) to Dec. 2025 (¥245.8 Mil).

Jiangsu Nanfang Medical Co Accounts Payable Related Terms

Jiangsu Nanfang Medical Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for Jiangsu Nanfang Medical Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Nanfang Medical Co Accounts Payable Chart

Jiangsu Nanfang Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 170.86 278.03 215.41 223.10 245.81

Jiangsu Nanfang Medical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 221.22 215.28 225.09 245.81 245.77
SHSE:603880
51GF Score
Jiangsu Nanfang Medical Co Ltd SHSE:603880
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Nanfang Medical Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ¥245.8 Mil mean?
Jiangsu Nanfang Medical Co (SHSE:603880) has a Accounts Payable of ¥245.8 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Jiangsu Nanfang Medical Co and its competitors.
Is Jiangsu Nanfang Medical Co's Accounts Payable too high?
Jiangsu Nanfang Medical Co's current Accounts Payable is ¥245.8 Mil. Overall, Jiangsu Nanfang Medical Co has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Nanfang Medical Co's Accounts Payable compare to ISRG and BDX?
Jiangsu Nanfang Medical Co's Accounts Payable of ¥245.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Jiangsu Nanfang Medical Co and its competitors. Jiangsu Nanfang Medical Co's current Accounts Payable is ¥245.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Nanfang Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Nanfang Medical Co (SHSE:603880) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.71, compared to a current price of ¥7.48 — trading 58.8% above its estimated fair value. The current Accounts Payable is ¥245.8 Mil. Jiangsu Nanfang Medical Co's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Jiangsu Nanfang Medical Co (SHSE:603880), the current Accounts Payable is ¥245.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Nanfang Medical Co (SHSE:603880) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Nanfang Medical Co stock appears to be overvalued. The current stock price of ¥7.48 is trading 58.8% above its estimated GF Value™ of ¥4.71. GuruFocus considers Jiangsu Nanfang Medical Co to be Significantly Overvalued.

Key valuation signals for SHSE:603880:

  • Accounts Payable: ¥245.8 Mil
  • GF Value™: ¥4.71 vs. price of ¥7.48 (58.8% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603880 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangsu Nanfang Medical Co Business Description

Address Guo Xiang Road, Economic Development Zone, Jiangsu Province, Wujin, CHN, 213149
Jiangsu Nanfang Medical Co Ltd is a domestic adhesive dressing production enterprise that integrates research and development, production, and sales. It produces a band-aid in China. The company is focused on the development of self-owned brand products such as first-aid kits, sports protection products, and care products on the basis of the original series of Miaoshou medical dressings.
51GF Score

Get the complete analysis for SHSE:603880

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.48
Price
¥4.71
GF Value